Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C5G6 | ISIN: DK0061670205 | Ticker-Symbol: N/A
1-Jahres-Chart
BRAIN+ A/S Chart 1 Jahr
5-Tage-Chart
BRAIN+ A/S 5-Tage-Chart

Aktuelle News zur BRAIN+ A/S Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09:09BRAIN+ A/S: Contract signed with Copenhagen Municipality on extended and expanded access to Ayla2
MiBrain+ A/S: Brain+ announces outcome of unit rights issue27Copenhagen, Denmark, 2 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA...
► Artikel lesen
26.03.BRAIN+ A/S: Brain+ A/S informs of last day to subscribe in its ongoing rights issue of units1
25.03.BRAIN+ A/S: Brain+ to close first UK Care Home partnership contract with Southcare Homes Group1
19.03.Brain+ A/S: Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators74Copenhagen, Denmark, 19 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S ("Brain+" or "the Company") today reports continued strong momentum in its sales pipeline, now exceeding €500...
► Artikel lesen
17.03.BRAIN+ A/S: The subscription period in Brain+' rights issue of units begins today1
BRAIN+ A/S Aktie jetzt für 0€ handeln
11.03.BRAIN+ A/S: UK care sector expert, Vishal Shah joins Brain+ as Advisor and Board Observer1
10.03.BRAIN+ A/S: The benefits of Ayla - your CST Assistant featured in CareTech, the healthtech media for Danish healthcare professionals1
06.03.Brain+ A/S: Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million78Copenhagen, Denmark, 6 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA...
► Artikel lesen
24.02.Brain+ A/S - reduction of share capital by reducing face value per share115The nominal share capital of Brain+ A/S will be reduced as of 26 February 2025 by reducing the face value of the company's shares from DKK 0.08 to DKK 0.01. Name: Brain+ ISIN: DK0061670205 Short...
► Artikel lesen
12.02.Brain+ A/S: Brain+ A/S - Minutes of Extraordinary General Meeting74Copenhagen, Denmark, 12 February 2025 - Brain+ A/S (Nasdaq First North: BRAINP) Today at 08:00 CEST, an Extraordinary General Meeting was held in Brain+ A/S ("Brain+" or "the Company"). A total of...
► Artikel lesen
30.01.BRAIN+ A/S: Invitation to Investor Webinar to update on sales outlook, restructuring and secured funding4
28.01.BRAIN+ A/S: Brain+ A/S - Notice of Extraordinary General Meeting1
22.01.Brain+ A/S: Brain+ restructures to reduce OPEX by 35%, maintaining €1M ARR target for end 2025 and now expecting break-even by mid-2026, and announces 50% secured intended Rights Issue98Copenhagen, Denmark, 22 January 2025 - Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S ("Brain+" or the "Company") announces that today, its Board of Directors has decided to carry out a rights issue...
► Artikel lesen
31.12.24BRAIN A/S: Brain+ announces change of Certified Advisor2
10.12.24BRAIN A/S: Brain+ invites to investor webinar to update on UK commercial pipeline and status2
05.12.24BRAIN A/S: Brain+ secures its first multi-year sales contract for Ayla - your CST Assistant with Syddjurs municipality4
01.11.24BRAIN A/S: Brain+ closes new Danish municipality sales contract on Ayla - your CST Assistant1
21.10.24BRAIN A/S: Brain+ progresses UK commercial outreach and hosts the first of a series of webinars on the value of Cognitive Stimulation Therapy1
11.10.24BRAIN A/S: Brain+ unveils new visual brand and website to elevate its Ayla Dementia Care solutions1
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1